Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study.

MLA

Pereira, Gerson Fernando Mendes, et al. “Dolutegravir and Pregnancy Outcomes in Women on Antiretroviral Therapy in Brazil: A Retrospective National Cohort Study.” The Lancet. HIV, vol. 8, no. 1, Jan. 2021, pp. e33–41. EBSCOhost, https://doi.org/10.1016/S2352-3018(20)30268-X.

APA

Pereira, G. F. M., Kim, A., Jalil, E. M., Fernandes Fonseca, F., Shepherd, B. E., Veloso, V. G., Rick, F., Ribeiro, R., Pimenta, M. C., Beber, A., Corrêa, R. G., Lima, R., Maruri, F., McGowan, C. C., Schwartz Benzaken, A., Grinsztejn, B., & Castilho, J. L. (2021). Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study. The Lancet. HIV, 8(1), e33–e41. https://doi.org/10.1016/S2352-3018(20)30268-X

Chicago

Pereira, Gerson Fernando Mendes, Ahra Kim, Emilia M Jalil, Fernanda Fernandes Fonseca, Bryan E Shepherd, Valdilea G Veloso, Fernanda Rick, et al. 2021. “Dolutegravir and Pregnancy Outcomes in Women on Antiretroviral Therapy in Brazil: A Retrospective National Cohort Study.” The Lancet. HIV 8 (1): e33–41. doi:10.1016/S2352-3018(20)30268-X.